Original Article

Archives of Virology

, Volume 159, Issue 8, pp 1901-1907

First online:

Determinants of poor outcome in patients with hepatitis A infection: a four-year retrospective study in Shiraz, Southern Iran

  • Kamran B. LankaraniAffiliated withCommunity and Preventive Medicine, Health Policy Research Centre, Shiraz University of Medical Sciences, School of Medicine
  • , Mojtaba MahmoodiAffiliated withCommunity and Preventive Medicine, Health Policy Research Centre, Shiraz University of Medical Sciences, School of Medicine
  • , Behnam HonarvarAffiliated withCommunity and Preventive Medicine, Health Policy Research Centre, Shiraz University of Medical Sciences, School of Medicine Email author 
  • , Parastoo NematollahiAffiliated withCommunity and Preventive Medicine, Health Policy Research Centre, Shiraz University of Medical Sciences, School of MedicineStudent Research Committee, Shiraz University of Medical Sciences
  • , Nima ZamiriAffiliated withCommunity and Preventive Medicine, Health Policy Research Centre, Shiraz University of Medical Sciences, School of Medicine
  • , Fariborz GhaffarpasandAffiliated withCommunity and Preventive Medicine, Health Policy Research Centre, Shiraz University of Medical Sciences, School of Medicine

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

There are 1.4 million estimated cases of hepatitis A every year worldwide. We aimed to detect the correlates of poor outcome in patients with hepatitis A virus (HAV) infection. In this four-year retrospective study, which was conducted in Shiraz, Southern Iran, data of all hospitalized HAV patients were analyzed by SPSS and STATA. Out of 110 HAV patients, 8 (7.3 %) developed hepatic encephalopathy, and 7 (6.4 %) died. The results show that 19 years of age is a cutoff level for predicting mortality, with a sensitivity of 42.9 % and specificity of 91.3 %, and with an area under the curve (AUC) of 0.595 (95 % CI, 0.309–0.881). Every one-year increase in age adds 3 % to the mortality rate from severe hepatitis A. The cutoff level of alanine aminotransferase (ALT) for predicting death is 1819.5 IU/L, with a sensitivity of 100 %, specificity of 68 %, and AUC 0.877 (95 % CI, 0.777–0.977). Every 100 IU/L increase in ALT is associated with a 0.1 % increase in the risk of death. Patients from large families (OR, 0.583, 95 % CI, 0.46–0.74) and those who are not the firstborn child of their family (OR, 0.287, 95 % CI, 0.146–0.564) have better outcome. Adult patients with hepatitis A who are first children, are from a small family, or have a very high level of ALT are more prone to a poor outcome of this infection. Public education and establishment of a national surveillance system for HAV and an HAV vaccination program for high-risk populations should be regarded among the priorities of the health system of Iran.